BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30
• 31

• Drug Development

  Amarin Corporation PLC Announces Additional Publication of MARINE Phase 3 Clinical Trial Results in the Journal of Clinical Lipidology

  August 29, 2012

   · 

  1 min read
• Drug Development

  Altheus Therapeutics Announces First Patient in Phase 2 Ulcerative Colitis Trial of Zoenasa®

  August 29, 2012

   · 

  2 min read
• Business

  Hyperion Therapeutics Appoints Daniel G. Welch to Board of Directors

  August 29, 2012

   · 

  1 min read
• Biotech Bay

  Align Technology, Inc. Executives to Present at Upcoming Financial Conferences

  August 29, 2012

   · 

  2 min read
• Biotech Bay

  Medivation, Inc. Announces a 2-for-1 Forward Split of Its Common Stock

  August 29, 2012

   · 

  1 min read
• Biotech Bay

  Threshold Pharmaceuticals, Inc. Announces Presentations and Webcasts at Two Upcoming Investor Conferences

  August 29, 2012

   · 

  2 min read
• Policy

  Veracyte, Inc. Receives New York State License for Afirma® Gene Expression Classifier

  August 29, 2012

   · 

  7 min read
• Drug Development

  Aerial BioPharma Receives FDA Orphan Drug Designation for Narcolepsy Drug in Development

  August 29, 2012

   · 

  1 min read
• Genetown

  Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Present Company Overview at the Stifel Nicolaus 2012 Healthcare Conference

  August 29, 2012

   · 

  1 min read
• Policy

  Noven Pharmaceuticals Inc. Submits New Drug Application for Investigational Non-Hormonal Therapy for Menopausal Vasomotor Symptoms

  August 29, 2012

   · 

  1 min read